PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
102 hedge funds and large institutions have $124M invested in Paratek Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 105 → 102 (-3)
48% less capital invested
Capital invested by funds: $238M → $124M (-$114M)
Holders
102
Holding in Top 10
4
Calls
$798K
Puts
$550K
Top Buyers
| 1 | +$3.94M | |
| 2 | +$1.2M | |
| 3 | +$1.02M | |
| 4 |
Renaissance Technologies
New York
|
+$663K |
| 5 |
APCM
Arbiter Partners Capital Management
New York
|
+$614K |
Top Sellers
| 1 | -$3.98M | |
| 2 | -$2.01M | |
| 3 | -$1.48M | |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.35M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$1.09M |